USE OF VONICOG ALFA: REPORTS OF PREGNANCIES OUTCOME IN TWO PATIENTS WITH TYPE 2 VON WILLEBRAND DISEASES (2VWD)

被引：0
|
作者：
Schell, B. [1 ]
Desprez, D. [2 ]
Sattler, L. [3 ]
de Raucourt, E. [4 ]
Flaujac, C. [1 ]
机构：
[1] Hop Andre Mignot Versailles, Sect Hemostase, Lab Biol Med, Le Chesnay, France
[2] Ctr Ressources & Competences Malad Hemorrag, Le Chesnay, France
[3] Ctr Hosp Reg Univ Strasbourg, Lab Hematol, Strasbourg, France
[4] Hop Andre Mignot Versailles, Ctr Ressources & Competences Malad Hemorrag, Le Chesnay, France
来源：
HAEMOPHILIA | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P215
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [31] New automated ristocetin cofactor activity assay to distinguish type 1 and type 2 von Willebrand Disease (VWD)
    Pinol, M.
    Sanchez, T.
    Sales, M.
    Vanrusselt, M.
    Arnout, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1146 - 1146
  • [32] Use of recombinant von Willebrand factor concentrate for peri-partum haemostatic management of women with type 2 VWD; a case series
    Turan, Ozlem
    Ndebele, Molly
    Abdul-Kadir, Rezan
    HAEMOPHILIA, 2024, 30 : 208 - 209
  • [33] Effect of von Willebrand disease (VWD) type 2B-like and pseudo-VWD mutations on the kinetics of von Willebrand factor domain A1 binding to platelet glycoprotein Ibα.
    Miura, S
    Li, CQ
    Cao, ZF
    Wang, HF
    Wardell, M
    Sadler, JE
    BLOOD, 1999, 94 (10) : 622A - 622A
  • [34] Densitometry of von Willebrand factor (VWF) multimers improves subtyping in type 2 von Willebrand disease (VWD) and quality control of factor VIII/VWF concentrates
    Studt, JD
    Budde, U
    Schneppenheim, R
    Prondzinski, MV
    Ganser, A
    Barthels, M
    THROMBOSIS AND HAEMOSTASIS, 1999, : 305 - 305
  • [35] Type 2N (Normandy) von Willebrand Disease (VWD) - a report of 3 cases misdiagnosed as hemophilia A
    Carcao, M.
    Stain, A.
    Lillicrap, D.
    Leggo, J.
    Blanchette, V.
    HAEMOPHILIA, 2010, 16 : 148 - 148
  • [36] An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 2 pedigrees.
    Kunicki, TJ
    Baronciani, L
    Canciani, MT
    Gianniello, F
    Federici, AB
    BLOOD, 2004, 104 (11) : 829A - 830A
  • [37] Type 2B von Willebrand disease (VWD) is characterized by a cytoskeletal desorganization in megakaryocytes leading to macrothrombocytopenia
    Kauskot, A.
    Poirault-Chassac, S.
    Casari, C.
    Adam, F.
    Pietrzyk-Nivau, A.
    Berrou, E.
    Bryckaert, M.
    Rosa, J-P
    Christophe, O. D.
    Lenting, P. J.
    Denis, C., V
    Baruch, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 184 - 185
  • [38] Von Willebrand disease (vWD) type 2B with atypical phenotype: Usefulness of mutation analysis.
    Brouwers, GJ
    Kappers-Klunne, MC
    Leebeek, FWG
    Gomez-Garcia, EB
    BLOOD, 2000, 96 (11) : 48A - 49A
  • [39] Gene Sequencing Aids in Differentiation of von Willebrand Disease Type 2B from Platelet-Type vWD
    Desai, Diana Shirish
    Lyon, Elaine
    Rodgers, George
    Jama, Mohamed
    Wallentine, Steven
    Smock, Kristi
    FASEB JOURNAL, 2013, 27
  • [40] Succesful prophylactic treatment of paediatric von Willebradn Disease (vWD) type 2and 3 with two different von Willebrand factor concentrate- a chort study
    Halimeh, S.
    Rott, H.
    Kruempel, A.
    Bogdanova, N.
    Kappert, G.
    Nowak-Goettl, U.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1150 - 1150
12345